Effects of lowering LDL cholesterol on progression of kidney disease.

Effects of lowering LDL cholesterol on progression of kidney disease.

Lowering LDL cholesterol reduces the risk of developing atherosclerotic events in CKD, but the effects of such treatment on progression of kidney disease remain uncertain. Here, 6245 participants with CKD (not on dialysis) were randomly assigned to simvastatin (20 mg) plus ezetimibe (10 mg) daily or...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Haynes, R, Lewis, D, Emberson, J, Reith, C, Agodoa, L, Cass, A, Craig, J, de Zeeuw, D, Feldt-Rasmussen, B, Fellström, B, Levin, A, Wheeler, D, Walker, R, Herrington, W, Baigent, C, Landray, M
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2014

Ижил төстэй зүйлс

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
-н: Storey, B, зэрэг
Хэвлэсэн: (2017)

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.
-н: Herrington, W, зэрэг
Хэвлэсэн: (2014)

Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
-н: Mihaylova, B, зэрэг
Хэвлэсэн: (2019)

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
-н: Baigent, C, зэрэг
Хэвлэсэн: (2011)

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
-н: Baigent, C, зэрэг
Хэвлэсэн: (2011)

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: Results from the study of heart and renal protection
-н: Reith, C, зэрэг
Хэвлэсэн: (2017)

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
-н: Cholesterol Treatment Trialists' Collaboration, зэрэг
Хэвлэсэн: (2016)

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection
-н: C. Reith, зэрэг
Хэвлэсэн: (2017-05-01)

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)
-н: Staplin, N, зэрэг
Хэвлэсэн: (2015)

Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP).
-н: Haynes, R, зэрэг
Хэвлэсэн: (2014)

Evaluating the contribution of the cause of kidney disease to prognosis in ckd: Results from the Study of Heart and Renal Protection (SHARP)
-н: Haynes, R, зэрэг
Хэвлэсэн: (2014)

Benefits of lowering cholesterol in chronic kidney disease Reply
-н: Baigent, C, зэрэг
Хэвлэсэн: (2011)

Smoking and adverse outcomes in patients With CKD: the Study of Heart and Renal Protection (SHARP)
-н: Emberson, J, зэрэг
Хэвлэсэн: (2016)

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.
-н: Mafham, M, зэрэг
Хэвлэсэн: (2017)

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
-н: Schlackow, I, зэрэг
Хэвлэсэн: (2017)

Evidence for reverse causality in the association between blood pressure and cardiovascular risk in patients with chronic kidney disease
-н: Herrington, W, зэрэг
Хэвлэсэн: (2016)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
-н: Baigent, C, зэрэг
Хэвлэсэн: (2011)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
-н: Baigent, C, зэрэг
Хэвлэсэн: (2011)

Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
-н: Baigent, C, зэрэг
Хэвлэсэн: (2010)

Use of causal diagrams to inform the analysis and interpretation of observational studies: An example from the Study of Heart and Renal Protection (SHARP)
-н: Staplin, N, зэрэг
Хэвлэсэн: (2016)

Misleading associations between cholesterol and vascular outcomes in dialysis patients: the need for randomized trials.
-н: Baigent, C, зэрэг
Хэвлэсэн: (2007)

Evidence for the prevention and treatment of stroke in dialysis patients
-н: Herrington, W, зэрэг
Хэвлэсэн: (2014)

Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP)
-н: Herrington, WG, зэрэг
Хэвлэсэн: (2023)

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
-н: Baigent, C, зэрэг
Хэвлэсэн: (2010)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
-н: Emberson, J, зэрэг
Хэвлэсэн: (2012)

Impact of CKD on household income
-н: Morton, R, зэрэг
Хэвлэсэн: (2017)

Conventional and genetic evidence on the association between adiposity and chronic kidney disease
-н: Zhu, P, зэрэг
Хэвлэсэн: (2020)

Impact of CKD on Household Income
-н: Rachael L. Morton, зэрэг
Хэвлэсэн: (2018-05-01)

Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank
-н: Zhu, P, зэрэг
Хэвлэсэн: (2020)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
-н: Mihaylova, B, зэрэг
Хэвлэсэн: (2012)

Impact of diabetes on the effects of sodium glucose co-transporter-2 (SGLT2) inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
-н: Herrington, W, зэрэг
Хэвлэсэн: (2022)

Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (the 3C Study) – results of a randomized controlled clinical trial
-н: Haynes, R, зэрэг
Хэвлэсэн: (2018)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
-н: John H. Contois, зэрэг
Хэвлэсэн: (2023-08-01)

Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy
-н: Storey, B, зэрэг
Хэвлэсэн: (2018)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
-н: Safi U. Khan, зэрэг
Хэвлэсэн: (2020-03-01)

Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure?
-н: Baigent, C, зэрэг
Хэвлэсэн: (2000)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
-н: Cholesterol Treatment Trialists' (CTT) Collaboration, зэрэг
Хэвлэсэн: (2012-01-01)

Conventional and genetic evidence on the association between adiposity and CKD
-н: Zhu, P, зэрэг
Хэвлэсэн: (2020)

Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men.
-н: Emberson, JR, зэрэг
Хэвлэсэн: (2010)

Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathwayss⃞
-н: Ming-Dong Wang, зэрэг
Хэвлэсэн: (2007-03-01)